Clinical significance of exosomal miRNAs and proteins in three human cancers with high mortality in China (Review)
- Authors:
- Li‑Man Li
- Huan Liu
- Xing‑Hui Liu
- Hong‑Bin Hu
- Song‑Mei Liu
-
Affiliations: Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Clinical Laboratory, Shanghai Gongli Hospital, The Second Military Medical University, Shanghai 200135, P.R. China, Department of Blood Transfusion, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430016, P.R. China - Published online on: October 29, 2018 https://doi.org/10.3892/ol.2018.9631
- Pages: 11-22
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Global Burden of Disease Cancer Collaboration, . Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al: Global, regional, and National cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 3:524–548. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H and Zou X: Report of cancer incidence and mortality in China, 2010. Ann Transl Med. 2:612014.PubMed/NCBI | |
|
Zheng R, Zeng H, Zhang S and Chen W: Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer. 36:662017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou L, Lv T, Zhang Q, Zhu Q, Zhan P, Zhu S, Zhang J and Song Y: The biology, function and clinical implications of exosomes in lung cancer. Cancer Lett. 407:84–92. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Qi H, Liu C, Long L, Ren Y, Zhang S, Chang X, Qian X, Jia H, Zhao J, Sun J, et al: Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano. 10:3323–3333. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Greening DW, Gopal SK, Xu R, Simpson RJ and Chen W: Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol. 40:72–81. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor DD and Gercel-Taylor C: Exosomes/microvesicles: Mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol. 33:441–454. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao L, Liu W, Xiao J and Cao B: The role of exosomes and ‘exosomal shuttle microRNA’ in tumorigenesis and drug resistance. Cancer Lett. 356:339–346. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kalluri R: The biology and function of exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Frydrychowicz M, Kolecka-Bednarczyk A, Madejczyk M, Yasar S and Dworacki G: Exosomes-structure, biogenesis and biological role in non-small-cell lung cancer. Scand J Immunol. 81:2–10. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Aqil F, Munagala R, Jeyabalan J, Agrawal AK and Gupta R: Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. AAPS J. 19:1691–1702. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Simons M and Raposo G: Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol. 21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schneider A and Simons M: Exosomes: Vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res. 352:33–47. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Mathivanan S, Ji H and Simpson RJ: Exosomes: Extracellular organelles important in intercellular communication. J Proteomics. 73:1907–1920. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Villarroya-Beltri C, Baixauli F, Gutiérrez-Vázquez C, Sánchez-Madrid F and Mittelbrunn M: Sorting it out: Regulation of exosome loading. Semin Cancer Biol. 28:3–13. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hannafon BN and Ding WQ: Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci. 14:14240–14269. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, Samuel M, Pathan M, Jois M, Chilamkurti N, et al: ExoCarta: A web-based compendium of exosomal cargo. J Mol Biol. 428:688–692. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ludwig AK and Giebel B: Exosomes: Small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 44:11–15. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Théry C, Zitvogel L and Amigorena S: Exosomes: Composition, biogenesis and function. Nat Rev Immunol. 2:569–579. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Iraci N, Leonardi T, Gessler F, Vega B and Pluchino S: Focus on extracellular vesicles: Physiological role and signalling properties of extracellular membrane vesicles. Int J Mol Sci. 17:1712016. View Article : Google Scholar : PubMed/NCBI | |
|
Li W, Li C, Zhou T, Liu X, Liu X, Li X and Chen D: Role of exosomal proteins in cancer diagnosis. Mol Cancer. 16:1452017. View Article : Google Scholar : PubMed/NCBI | |
|
Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC and Ding WQ: Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol Cancer. 14:1332015. View Article : Google Scholar : PubMed/NCBI | |
|
Kapetanakis NI, Baloche V and Busson P: Tumor exosomal microRNAs thwarting anti-tumor immune responses in nasopharyngeal carcinomas. Ann Transl Med. 5:1642017. View Article : Google Scholar : PubMed/NCBI | |
|
Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R, Grinspoon SK, et al: Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 542:450–455. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ying W, Riopel M, Bandyopadhyay G, Dong Y, Birmingham A, Seo JB, Ofrecio JM, Wollam J, Hernandez-Carretero A, Fu W, et al: Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell. 171:372–384.e12. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shi R, Zhao L, Cai W, Wei M, Zhou X, Yang G and Yuan L: Maternal exosomes in diabetes contribute to the cardiac development deficiency. Biochem Biophys Res Commun. 483:602–608. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Milane L, Singh A, Mattheolabakis G, Suresh M and Amiji MM: Exosome mediated communication within the tumor microenvironment. J Control Release. 219:278–294. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z: miRNA in plasma exosome is stable under different storage conditions. Molecules. 19:1568–1575. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pfeffer SR, Grossmann KF, Cassidy PB, Yang CH, Fan M, Kopelovich L, Leachman SA and Pfeffer LM: Detection of exosomal miRNAs in the plasma of melanoma patients. J Clin Med. 4:2012–2027. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Watahiki A, Macfarlane RJ, Gleave ME, Crea F, Wang Y, Helgason CD and Chi KN: Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer. Int J Mol Sci. 14:7757–7770. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xu R, Greening DW, Rai A, Ji H and Simpson RJ: Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods. 87:11–25. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Subra C, Laulagnier K, Perret B and Record M: Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie. 89:205–212. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Record M, Carayon K, Poirot M and Silvente-Poirot S: Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 1841:108–120. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Raposo G and Stoorvogel W: Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol. 200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li P, Kaslan M, Lee SH, Yao J and Gao Z: Progress in exosome isolation techniques. Theranostics. 7:789–804. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Caradec J, Kharmate G, Hosseini-Beheshti E, Adomat H, Gleave M and Guns E: Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem. 47:1286–1292. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Baranyai T, Herczeg K, Onódi Z, Voszka I, Módos K, Marton N, Nagy G, Mäger I, Wood MJ, El Andaloussi S, et al: Isolation of exosomes from blood plasma: Qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One. 10:e01456862015. View Article : Google Scholar : PubMed/NCBI | |
|
Peterson MF, Otoc N, Sethi JK, Gupta A and Antes TJ: Integrated systems for exosome investigation. Methods. 87:31–45. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lu L and Risch HA: Exosomes: Potential for early detection in pancreatic cancer. Future Oncol. 12:1081–1090. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zeringer E, Barta T, Li M and Vlassov AV: Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015:319–323. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor DD and Shah S: Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 87:3–10. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ban JJ, Lee M, Im W and Kim M: Low pH increases the yield of exosome isolation. Biochem Biophys Res Commun. 461:76–79. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Marczak S, Richards K, Ramshani Z, Smith E, Senapati S, Hill R, Go DB and Chang HC: Simultaneous isolation and preconcentration of exosomes by ion concentration polarization. Electrophoresis. Feb 27–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI | |
|
Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM and Simpson RJ: Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 56:293–304. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Vaswani K, Koh YQ, Almughlliq FB, Peiris HN and Mitchell MD: A method for the isolation and enrichment of purified bovine milk exosomes. Reprod Biol. 17:341–348. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Muller L, Hong CS, Stolz DB, Watkins SC and Whiteside TL: Isolation of biologically-active exosomes from human plasma. J Immunol Methods. 411:55–65. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, et al: Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2:2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kadota T, Yoshioka Y, Fujita Y, Kuwano K and Ochiya T: Extracellular vesicles in lung cancer-From bench to bedside. Semin Cell Dev Biol. 67:39–47. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Nanavaty P, Alvarez MS and Alberts WM: Lung cancer screening: Advantages, controversies, and applications. Cancer Control. 21:9–14. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Pletnikoff PP, Laukkanen JA, Tuomainen TP, Kauhanen J, Rauramaa R, Ronkainen K and Kurl S: Cardiorespiratory fitness, C-reactive protein and lung cancer risk: A prospective population-based cohort study. Eur J Cancer. 51:1365–1370. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD and Kloecker GH: Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer. 10:42–46. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Munagala R, Aqil F and Gupta RC: Exosomal miRNAs as biomarkers of recurrent lung cancer. Tumour Biol. 37:10703–10714. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L and Li Y: Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Oncotarget. 8:13048–13058. 2017.PubMed/NCBI | |
|
Yamashita T, Kamada H, Kanasaki S, Maeda Y, Nagano K, Abe Y, Inoue M, Yoshioka Y, Tsutsumi Y, Katayama S, et al: Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Pharmazie. 68:969–973. 2013.PubMed/NCBI | |
|
Sandfeld-Paulsen B, Aggerholm-Pedersen N, Bæk R, Jakobsen KR, Meldgaard P, Folkersen BH, Rasmussen TR, Varming K, Jørgensen MM and Sorensen BS: Exosomal proteins as prognostic biomarkers in non-small cell lung cancer. Mol Oncol. 10:1595–1602. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ueda K, Ishikawa N, Tatsuguchi A, Saichi N, Fujii R and Nakagawa H: Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes. Sci Rep. 4:62322014. View Article : Google Scholar : PubMed/NCBI | |
|
Ostrowski K and Kinsner A: Inhibition of angiogenesis in the treatment of tumors. Arch Immunol Ther Exp (Warsz). 49:27–31. 2001.PubMed/NCBI | |
|
Liu Y, Luo F, Wang B, Li H, Xu Y, Liu X, Shi L, Lu X, Xu W, Lu L, et al: STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells. Cancer Lett. 370:125–135. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hsu YL, Hung JY, Chang WA, Lin YS, Pan YC, Tsai PH, Wu CY and Kuo PL: Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene. 36:4929–4942. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al: MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA. 109:E2110–E2116. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D and Feng J: Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 12:3721–3733. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yuwen DL, Sheng BB, Liu J, Wenyu W and Shu YQ: MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 21:2650–2658. 2017.PubMed/NCBI | |
|
Lobb RJ, van Amerongen R, Wiegmans A, Ham S, Larsen JE and Möller A: Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance. Int J Cancer. 141:614–620. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang FS, Fan JG, Zhang Z, Gao B and Wang HY: The global burden of liver disease: The major impact of China. Hepatology. 60:2099–2108. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li X and Xu WF: China's efforts to shed its title of ‘Leader in liver disease’. Drug Discov Ther. 1:84–85. 2007.PubMed/NCBI | |
|
Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FD, Leung C, Wang HH, Wong GL, Wong VW and Chan HL: International incidence and mortality trends of liver cancer: A global profile. Sci Rep. 7:458462017. View Article : Google Scholar : PubMed/NCBI | |
|
Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG and Paik YH: Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med. 47:e1842015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Hou L, Li A, Duan Y, Gao H and Song X: Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int. 2014:8648942014.PubMed/NCBI | |
|
Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J and Zhou J: Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma. Onco Targets Ther. 10:3843–3851. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kogure T, Lin WL, Yan IK, Braconi C and Patel T: Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 54:1237–1248. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wei JX, Lv LH, Wan YL, Cao Y, Li GL, Lin HM, Zhou R, Shang CZ, Cao J, He H, et al: Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells. Hepatology. 61:1284–1294. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mishra SK, Siddique HR and Saleem M: S100A4 calcium-binding protein is key player in tumor progression and metastasis: Preclinical and clinical evidence. Cancer Metastasis Rev. 31:163–172. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tse EY, Ko FC, Tung EK, Chan LK, Lee TK, Ngan ES, Man K, Wong AS, Ng IO and Yam JW: Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis. J Pathol. 226:645–653. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cokakli M, Erdal E, Nart D, Yilmaz F, Sagol O, Kilic M, Karademir S and Atabey N: Differential expression of Caveolin-1 in hepatocellular carcinoma: Correlation with differentiation state, motility and invasion. BMC Cancer. 9:652009. View Article : Google Scholar : PubMed/NCBI | |
|
He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF and Wong N: Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. Carcinogenesis. 36:1008–1018. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, et al: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 10:25–34. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lou G, Song X, Yang F, Wu S, Wang J, Chen Z and Liu Y: Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 8:1222015. View Article : Google Scholar : PubMed/NCBI | |
|
You H, Ding W, Dang H, Jiang Y and Rountree CB: c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology. 54:879–889. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Qu Z, Wu J, Wu J, Luo D, Jiang C and Ding Y: Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro. J Exp Clin Cancer Res. 35:1592016. View Article : Google Scholar : PubMed/NCBI | |
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N: Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peleteiro B, Severo M, La Vecchia C and Lunet N: Model-based patterns in stomach cancer mortality worldwide. Eur J Cancer Prev. 23:524–531. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang N, Wang L, Yang Y, Gong L, Xiao B and Liu X: A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Biochem Biophys Res Commun. 493:1322–1328. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tokuhisa M, Ichikawa Y, Kosaka N, Ochiya T, Yashiro M, Hirakawa K, Kosaka T, Makino H, Akiyama H, Kunisaki C and Endo I: Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer. PLoS One. 10:e01304722015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Z, Zhu D, Wu L, He M, Zhou X, Zhang L, Zhang H, Wang W, Zhu J, Cheng W, et al: Six serum-based miRNAs as potential diagnostic biomarkers for gastric cancer. Cancer Epidemiol Biomarkers Prev. 26:188–196. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Zhao C, Shi H, Zhang B, Zhang L, Zhang X, Wang S, Wu X, Yang T, Huang F, et al: Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: Novel biomarkers and a mechanism for gastric cancer. Br J Cancer. 110:1199–1210. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Deng T, Liu R, Bai M, Zhou L, Wang X, Li S, Wang X, Yang H, Li J, et al: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat Commun. 8:150162017. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Liu DR, Li GG, Wang HH, Li XW, Zhang W, Wu YL and Chen L: CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. World J Gastroenterol. 21:6215–6228. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu D, Li C, Trojanowicz B, Li X, Shi D, Zhan C, Wang Z and Chen L: CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent. Gastric Cancer. 19:754–766. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong H, Yang Y, Ma S, Xiu F, Cai Z, Zhao H and Du L: Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients. Int J Hyperthermia. 27:604–611. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Broere F, van der Zee R and van Eden W: Heat shock proteins are no DAMPs, rather ‘DAMPERs’. Nat Rev Immunol. 11:5652011. View Article : Google Scholar : PubMed/NCBI | |
|
van Eden W, Spiering R, Broere F and van der Zee R: A case of mistaken identity: HSPs are no DAMPs but DAMPERs. Cell Stress Chaperones. 17:281–292. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie G, Ma Y and Shen L: Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Zhang H, Bai M, Ning T, Ge S, Deng T, Liu R, Zhang L, Ying G and Ba Y: Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer. Mol Ther. 26:774–783. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ji R, Zhang B, Zhang X, Xue J, Yuan X, Yan Y, Wang M, Zhu W, Qian H and Xu W: Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer. Cell Cycle. 14:2473–2483. 2015. View Article : Google Scholar : PubMed/NCBI |
